14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 8 May 2024

Trading levels for AMPE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.241 .
R2 0.241 .
R1 0.241 .
Current price: 0.241
Support S1 0.241 .
S2 0.241 .
S3 0.241 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.300 24.74 %
R2 0.250 3.95 %
R1 0.242 0.622 %
Current price 0.241
Support S1 0.225 -6.45%
S2 0 .
S3 0 .

AMPE Predictions History

3 years ago
Rick Murphy predicted that AMPE for 2020-12-03 is going $1.75 (62.04%)

Rank:

3 years ago
JS predicted that AMPE for 2020-12-02 is going $0.89 (-13.30%)

3 years ago
sander7100 yo bro predicted that AMPE for 2020-09-28 is going $0.96 (4.02%)

3 years ago
JS predicted that AMPE for 2020-09-28 is going $0.98 (6.63%)

3 years ago
iHustle84 predicted that AMPE for 2020-09-28 is going $1.00 (8.70%)

4 years ago
JS predicted that AMPE for 2020-03-06 is going $0.604 (3.28%)

4 years ago
Rachel predicted that AMPE for 2020-03-06 is going

Rank:

5 years ago
NameNotImportant predicted that AMPE for 2019-05-06 is going $0.591 (4.34%)

5 years ago
NameNotImportant predicted that AMPE for 2019-05-03 is going $0.551 (-2.72%)

5 years ago
NameNotImportant predicted that AMPE for 2019-04-29 is going $0.535 (-3.11%)

Click to get the best stock tips daily for free!

About Ampio Pharmaceuticals Inc

Ampio Pharmaceuticals Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requi... AMPE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT